According to Tango Therapeutics's latest financial reports the company has $0.29 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $0.36 B | -24.55% |
2021-12-31 | $0.48 B | 154.97% |
2020-12-31 | $0.19 B |